Peptidomimetics in cancer targeting

The low efficiency of treatment strategies is one of the main obstacles to developing cancer inhibitors. Up to now, various classes of therapeutics have been developed to inhibit cancer progression. Peptides due to their small size and easy production compared to proteins are highly regarded in desi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomari, Mohammad Mahmoudi, Abkhiz, Shadi, Pour, Taha Ghantab, Lotfi, Ehsan, Rostami, Neda, Monfared, Fatemeh Nafe, Ghobari, Babak, Mosavi, Mona, Alipour, Behruz, Dokholyan, Nikolay V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730693/
https://www.ncbi.nlm.nih.gov/pubmed/36476230
http://dx.doi.org/10.1186/s10020-022-00577-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730693/
https://www.ncbi.nlm.nih.gov/pubmed/36476230
http://dx.doi.org/10.1186/s10020-022-00577-3

Ejemplares similares